BCL2 and colorectal cancer: Sertraline demonstrated strong anticancer activity in colorectal cancer, particularly in multi‐drug‐resistant cells, through a combination of cell cycle arrest, apoptosis induction, Bcl‐2 inhibition, and c‐Jun activationSertraline showed higher efficacy in multi‐drug resistant LS1034 cells than traditional chemotherapy drugs